Expanding the Reach of RNAi Therapeutics with Next Generation Lipophilic siRNA Conjugates

Kirk Brown(John Hunter Hospital), Vasant Jadhav(Alnylam Pharmaceuticals (United States))
Research Square
October 21, 2021
10.21203/rs.3.rs-946835/v1
Cited by 3

Related Papers

Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
|Nature Biotechnology|2022|239
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis
|Molecular Therapy — Nucleic Acids|2013|37
Artificial Selection: Finding Function amongst Randomized Sequences
|Unknown|2005|1